Product NDC: | 67253-580 |
Proprietary Name: | Rheumatrex |
Non Proprietary Name: | Methotrexate |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Methotrexate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67253-580 |
Labeler Name: | DAVA Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA008085 |
Marketing Category: | NDA |
Start Marketing Date: | 19530712 |
Package NDC: | 67253-580-45 |
Package Description: | 4 BLISTER PACK in 1 CARTON (67253-580-45) > 5 TABLET in 1 BLISTER PACK |
NDC Code | 67253-580-45 |
Proprietary Name | Rheumatrex |
Package Description | 4 BLISTER PACK in 1 CARTON (67253-580-45) > 5 TABLET in 1 BLISTER PACK |
Product NDC | 67253-580 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methotrexate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19530712 |
Marketing Category Name | NDA |
Labeler Name | DAVA Pharmaceuticals, Inc. |
Substance Name | METHOTREXATE SODIUM |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |